Changzhou Qianhong Biopharma Co Ltd - Class A

SZSE:002550 (China)   Class A
Â¥ 4.91 (+0.41%) Mar 28
25.86
P/B:
2.56
Market Cap:
Â¥ 6.28B ($ 869.41M)
Enterprise V:
Â¥ 5.78B ($ 799.07M)
Volume:
8.49M
Avg Vol (2M):
13.00M
Volume:
8.49M
Avg Vol (2M):
13.00M

Business Description

Description
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.
Name Current Vs Industry Vs History
Cash-To-Debt 25.11
Equity-to-Asset 0.9
Debt-to-Equity 0.01
Debt-to-EBITDA 0.07
Interest Coverage 36.13
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 16.82
Distress
Grey
Safe
Beneish M-Score -2.71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.69
9-Day RSI 34.46
14-Day RSI 39.92
6-1 Month Momentum % -4.41
12-1 Month Momentum % -17.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.93
Quick Ratio 4.99
Cash Ratio 2.94
Days Inventory 185.39
Days Sales Outstanding 74.92
Days Payable 13.77

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 2.45
Dividend Payout Ratio 0.79
Forward Dividend Yield % 2.45
5-Year Yield-on-Cost % 4.32
Shareholder Yield % 1.97
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Changzhou Qianhong Biopharma Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 2,120.66
EPS (TTM) (Â¥) 0.191
Beta 0.13
Volatility % 23.31
14-Day RSI 39.92
14-Day ATR (Â¥) 0.128077
20-Day SMA (Â¥) 5.063
12-1 Month Momentum % -17.66
52-Week Range (Â¥) 4.2 - 6.34
Shares Outstanding (Mil) 1,279.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Changzhou Qianhong Biopharma Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Changzhou Qianhong Biopharma Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Changzhou Qianhong Biopharma Co Ltd Frequently Asked Questions

What is Changzhou Qianhong Biopharma Co Ltd(SZSE:002550)'s stock price today?
The current price of SZSE:002550 is ¥4.91. The 52 week high of SZSE:002550 is ¥6.34 and 52 week low is ¥4.20.
When is next earnings date of Changzhou Qianhong Biopharma Co Ltd(SZSE:002550)?
The next earnings date of Changzhou Qianhong Biopharma Co Ltd(SZSE:002550) is .
Does Changzhou Qianhong Biopharma Co Ltd(SZSE:002550) pay dividends? If so, how much?
The  Dividend Yield %  of Changzhou Qianhong Biopharma Co Ltd(SZSE:002550) is 2.45% (As of Today), Highest Dividend Payout Ratio of Changzhou Qianhong Biopharma Co Ltd(SZSE:002550) was 1.92. The lowest was 0.44. And the median was 0.82. The  Forward Dividend Yield % of Changzhou Qianhong Biopharma Co Ltd(SZSE:002550) is 2.45%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release